| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
How Are DCTs Impacting Your Clinical Sites?
|
| |
|
From The Editor |
By Ed Miseta, chief editor, Clinical Leader
|
| |
Where do your sites stand on DCTs? For this article, we spoke with three site experts who discussed the pain points of DCTs, including costs, budgeting, training, support, staffing, resources, and more.
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
2 Strategies For Rare Disease Clinical Research Patient Centricity
|
| |
|
Guest Column |
By Eugene Sullivan, M.D., Insmed
|
| |
|
We all know it is important in rare disease clinical research to seek out the knowledge of clinical and academic experts who can inform study design. But we need to better prioritize the patient's voice. By prioritizing patient involvement throughout the process — listening to their insights and understanding their needs — we can achieve even greater progress.
|
| |
|
|
|
| |
|
|
|
|
Building A Patient-Centric Community
|
| |
|
Podcast |
Biorasi
|
| |
Join the latest Few & Far Between podcast episode and explore patients' power and determination when it comes to finding a treatment for rare diseases.
|
| |
|
|
|
| |
|
|
|
|
How To Increase Access To Femtech Clinical Trials
|
| |
|
Article |
Elligo Health Research
|
| |
The rapid expansion of the Femtech industry is translating into increased Femtech clinical trials. Sponsors looking to enable broader participation should consider these potential solutions.
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
| |
|
|
| |
The 2023 PDA Advanced Therapy Medicinal Products Conference, June 7-8, in Baltimore, MD, will focus on the theme, “Navigating through CMC Challenges.” This popular conference will offer a forum for sharing best practices and learning from the experts how the industry is applying novel approaches to a wide variety of topics relating to cell and gene therapies. Register now!
|
| |
|
|
| |
|
|
|
|
|
| |
|
|
|
|
Walgreens Is Ready To Re-Envision Recruitment, DCTs, And RWE
|
| |
|
From The Editor |
By Ed Miseta, chief editor, Clinical Leader
|
| |
Since becoming CEO of Walgreens Boots Alliance (WBA) in March 2021, Rosalind Brewer has been focused on healthcare and what the company could do to help its patients. WBA refers to the integrated healthcare, pharmacy, and retail store that currently serves millions of customers and patients every day. This past June, the company launched its clinical trial business.
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
| |
You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.
- Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here.
|
| |
|
|
| |
|
|
|
|
|
|
|
|
